University Of Southampton
Clinical trials sponsored by University Of Southampton, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- App alerts COPD patients when their inhalers may be out of date Results expected Sep 2026 (estimated)
- Volunteer-led walks aim to stop muscle loss in older hospital patients Results expected Nov 2026 (estimated)
- Scientists deliberately infect volunteers with whooping cough to study natural defenses Results expected Dec 2026 (estimated)
- New supplement aims to ease menopause-related body changes in midlife women Results expected Dec 2026 (estimated)
- New stent aims to cut infections and hospital visits for kidney and cancer patients Results expected Dec 2026 (estimated)
-
Experimental vaccine aims to shrink colorectal tumors before surgery
Disease control Stopped earlyThis trial tested a vaccine called PD1-Vaxx given before surgery to people with a specific type of colorectal cancer (MSI-high). The goal was to see if the vaccine could shrink tumors, measured by how many cancer cells remained after treatment. Only 3 people took part, and the st…
Phase 2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Aspirin study for kidney patients halted early – did the risks outweigh the benefits?
Disease control Stopped earlyThis study looked at whether taking a daily low-dose aspirin could help people with chronic kidney disease avoid their first heart attack or stroke. Over 4,600 participants were randomly assigned to take aspirin or receive usual care. The trial was stopped early, and the final re…
Phase 3 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC